Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing Cognition in Mice.
Hölter SM, Garrett L, Einicke J, Sperling B, Dirscherl P, Zimprich A, Fuchs H, Gailus-Durner V, Hrabě de Angelis M, Wurst W. Hölter SM, et al. Among authors: sperling b. Curr Protoc Mouse Biol. 2015 Dec 2;5(4):331-358. doi: 10.1002/9780470942390.mo150068. Curr Protoc Mouse Biol. 2015. PMID: 26629775
Tests for Anxiety-Related Behavior in Mice.
Hölter SM, Einicke J, Sperling B, Zimprich A, Garrett L, Fuchs H, Gailus-Durner V, Hrabé de Angelis M, Wurst W. Hölter SM, et al. Among authors: sperling b. Curr Protoc Mouse Biol. 2015 Dec 2;5(4):291-309. doi: 10.1002/9780470942390.mo150010. Curr Protoc Mouse Biol. 2015. PMID: 26629773
Assessing Sociability, Social Memory, and Pup Retrieval in Mice.
Zimprich A, Niessing J, Cohen L, Garrett L, Einicke J, Sperling B, Schmidt MV, Hölter SM. Zimprich A, et al. Among authors: sperling b. Curr Protoc Mouse Biol. 2017 Dec 20;7(7):287-305. doi: 10.1002/cpmo.36. Curr Protoc Mouse Biol. 2017. PMID: 29261230
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
Ashina M, Lipton RB, Ailani J, Versijpt J, Sacco S, Mitsikostas DD, Christoffersen CL, Sperling B, Ettrup A. Ashina M, et al. Among authors: sperling b. Eur J Neurol. 2024 Feb;31(2):e16131. doi: 10.1111/ene.16131. Epub 2023 Nov 13. Eur J Neurol. 2024. PMID: 37955557 Free PMC article. Clinical Trial.
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
Ailani J, McAllister P, Winner PK, Chakhava G, Josiassen MK, Lindsten A, Sperling B, Ettrup A, Cady R. Ailani J, et al. Among authors: sperling b. BMC Neurol. 2023 Sep 6;23(1):318. doi: 10.1186/s12883-023-03368-3. BMC Neurol. 2023. PMID: 37674117 Free PMC article. No abstract available.
Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study.
Ashina M, Lanteri-Minet M, Ettrup A, Christoffersen CL, Josiassen MK, Phul R, Sperling B, Pozo-Rosich P. Ashina M, et al. Among authors: sperling b. Cephalalgia. 2023 May;43(5):3331024231170807. doi: 10.1177/03331024231170807. Cephalalgia. 2023. PMID: 37125484 Free article. Clinical Trial.
91 results